Crescent Biopharma Ratios (2013-2026) | CBIO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
EBT Margin (Quarter)	-10,140,324.65%	-20,023.48%	-98,847.07%		-17,690.09%															-2,240.90%
EBIT Margin (Quarter)	-10,144,001.41%	-20,028.82%	-98,870.20%		-17,804.21%															-2,380.08%
EBITDA Margin (Quarter)	-10,144,001.41%	-20,028.82%	-98,870.20%		-17,804.21%															-2,240.90%
Operating Margin (Quarter)	-10,144,001.41%	-20,028.82%	-98,870.20%		-17,804.21%															-2,380.08%
Net Margin (Quarter)	-10,140,324.65%	-20,023.48%	-98,847.07%		-17,690.09%															-2,240.90%
FCF Margin (Quarter)	-9,589,105.63%	-19,582.49%	-72,675.25%		-21,695.80%															-870.74%
Efficiency
Assets Average (Quarter)	131.20M	116.16M	101.15M	87.91M	73.25M	60.50M	53.89M	60.37M	65.37M	57.51M	49.26M	39.76M	29.31M	20.06M	25.66M	20.80M	81.71M	147.85M	189.28M	219.71M
Equity Average (Quarter)	118.70M	104.43M	89.08M	74.82M	61.88M	51.92M	45.52M	52.56M	58.49M	50.67M	42.48M	33.66M	24.49M	9.38M	-8.39M	-22.82M	54.55M	127.95M	159.83M	193.43M
Invested Capital (Quarter)	112.29M	96.57M	81.60M	68.03M	55.73M	48.12M	42.93M	62.18M	54.80M	46.55M	38.41M	28.91M	20.06M	-1.30M	-15.48M	-30.16M	139.25M	116.64M	203.01M	183.85M
Asset Utilization Ratio (Quarter)	0.02	0.01	0.01		0.00	0.00	0.00								0.00					0.00
Leverage & Solvency
Interest Coverage Ratio (Quarter)															-20.18	-12.79	-19.60
Debt to Equity (Quarter)															-2.42
Debt Ratio (Quarter)															1.05
Equity Ratio (Quarter)	0.90	0.89	0.86	0.84	0.86	0.86	0.83	0.90	0.89	0.87	0.85	0.85	0.82	-0.08	-0.43	-5.03	0.88	0.84	0.84	0.92
Times Interest Earned (Quarter)															-20.18	-12.79	-19.60
Valuation
Enterprise Value (Quarter)	-118.85M	-101.92M	-90.25M	-76.52M	-60.20M	-51.60M	-47.87M	-65.00M	-58.04M	-49.41M	-41.79M	-31.28M	-22.40M	-14.40M	-34.77M	-22.43M		-133.26M	-213.19M	-189.16M
Return Ratios
Return on Sales (Quarter)	-1,014.03%	-2.00%	-9.88%		-1.77%	-3.01%	-5.04%								-5.51%					-0.22%
Return on Capital Employed (Quarter)	-47.94%	-57.83%	-71.03%	-84.96%	-97.60%	-102.75%	-105.33%	-81.46%	-66.77%	-78.85%	-92.58%	-114.46%	-163.80%	-214.12%	-257.39%	-244.14%	-84.78%	-61.41%	-99.62%	-79.38%
Return on Assets (Quarter)	0.00%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.02%	-0.02%	-0.02%	-0.01%	-0.01%	-0.01%	-0.01%
Return on Equity (Quarter)	0.00%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.02%	-0.03%	0.05%	0.02%	-0.01%	-0.01%	-0.01%	-0.01%

Research Tools

Developers

Crescent Biopharma Ratios (2013-2026) | CBIO

Research Tools

Developers

Crescent Biopharma Ratios (2013-2026) | CBIO

Create an account

Sign In

Reset Password